Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
Turco F, Gillessen S, Treglia G, Fizazi K, Smith MR, Tombal B, Cathomas R, Buttigliero C, Di Maio M, Tucci M, Vogl UM. Turco F, et al. Among authors: di maio m. Prostate Cancer Prostatic Dis. 2023 Dec 14. doi: 10.1038/s41391-023-00775-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 38097723 Review.
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer.
Bertaglia V, Tucci M, Vignani F, Buttigliero C, Aroasio E, Berruti A, Scagliotti GV, DI Maio M. Bertaglia V, et al. Among authors: di maio m. Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22. Minerva Urol Nefrol. 2017. PMID: 28008755 Free article.
Zoledronic Acid Dosing Interval for Metastatic Cancer.
Tucci M, Buttigliero C, Di Maio M. Tucci M, et al. Among authors: di maio m. JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562. JAMA. 2017. PMID: 28399243 No abstract available.
637 results